AlphaCrest Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,108
Closed -$1.29M 364
2022
Q3
$1.29M Buy
18,108
+13,995
+340% +$1.26M 0.08% 446
2022
Q2
$369K Sell
4,113
-12,914
-76% -$1.34M 0.02% 1042
2022
Q1
$1.91M Buy
17,027
+4,643
+37% +$544K 0.11% 257
2021
Q4
$1.5M Buy
12,384
+1,360
+12% +$151K 0.06% 595
2021
Q3
$1.11M Buy
11,024
+2,919
+36% +$322K 0.06% 568
2021
Q2
$946K Sell
8,105
-2,470
-23% -$297K 0.04% 688
2021
Q1
$1.17M Buy
10,575
+5,600
+113% +$608K 0.06% 431
2020
Q4
$499K Buy
+4,975
New +$461K 0.04% 647
2020
Q3
Sell
-3,674
Closed -$256K 1120
2020
Q2
$256K Sell
3,674
-21,118
-85% -$1.33M 0.04% 704
2020
Q1
$1.16M Buy
24,792
+9,820
+66% +$631K 0.14% 218
2019
Q4
$1.19M Sell
14,972
-8,936
-37% -$687K 0.1% 271
2019
Q3
$1.76M Buy
23,908
+15,325
+179% +$1.1M 0.11% 290
2019
Q2
$668K Sell
8,583
-8,664
-50% -$658K 0.06% 582
2019
Q1
$1.31M Buy
17,247
+12,865
+294% +$1.02M 0.2% 118
2018
Q4
$320K Buy
+4,382
New +$349K 0.1% 421

Other funds holding EMN

AlphaCrest Capital Management's EMN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Eastman Chemical (EMN) in Q4 2022, closing a stake of 18,108 shares — an estimated $1.29M sold.

AlphaCrest Capital Management first reported a position in EMN in Q4 2018 and held it in 15 quarters. The position peaked at $1.91M in Q1 2022. 706 funds tracked by Wall St. Rank hold EMN as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Eastman Chemical position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 18,108 Eastman Chemical shares in Q4 2022, an estimated $1.29M.
  • AlphaCrest Capital Management first reported a position in Eastman Chemical in Q4 2018 and held it in 15 quarters.
  • AlphaCrest Capital Management's Eastman Chemical position peaked at $1.91M in Q1 2022.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.